EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Bulk and Single‐Cell Transcriptomic Analysis Reveals Xenobiotic Metabolism Genes Drive Progression From Liver Cirrhosis to Hepatocellular Carcinoma

Hao Xu, Yanpeng Li, Rui Zhao, Shaowei Ma iD, Ning Hu iD, Shuo Yu iD, Xuefeng Lv iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/6845605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 13.05.2026. Verfasst von Hao Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, zdsfy.net. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Cirrhosis, Xenobiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors globally, with liver cirrhosis (LC) recognized as a significant precursor. Xenobiotic metabolism plays a pivotal role in liver diseases, where the liver′s primary function as a detoxifying organ directly influences health and tumor development. Therefore, exploring the function of genes associated with xenobiotic metabolism in patients with HCC and LC is crucial for advancing diagnosis and treatment strategies.

Methods

This study integrated bulk transcriptome RNA sequencing and single‐cell RNA sequencing data of HCC and LC from the GEO database. Differential expression analysis, GO and DO enrichment analyses, and PPI network construction were performed to identify hub genes. ROC curve analysis was used to assess the diagnostic value of these genes, and potential therapeutic drugs were predicted using drug databases. The expression of the identified hub genes was validated in clinical tissue samples (≥ 10 pairs) by qRT‐PCR and Western blot. Functional assays, including wound healing, transwell migration, and invasion assays, were conducted following siRNA‐mediated knockdown of selected hub genes in Huh7 hepatoma cells.

Results

We identified five key xenobiotic metabolism‐related hub genes: AKR1C3, CYB5A, ADH1C, MAOA, and ALDH2. These genes were significantly overexpressed in HCC and LC tissues compared with normal tissues and were associated with xenobiotic metabolism, substance abuse, alcohol use disorders, and cancer. ROC curve analysis indicated that these hub genes have high diagnostic value in HCC and LC. Potential drug prediction identified six compounds, including retinal, isopropanol, and disulfiram, which may have therapeutic effects. Clinical tissue validation confirmed that all five hub genes were significantly upregulated at both mRNA and protein levels in HCC and LC tissues compared with normal controls ( p < 0.05). Functional experiments demonstrated that knockdown of ALDH2 or AKR1C3 significantly impaired the migration and invasion abilities of Huh7 cells, with a reduction of over 50% in transwell assays ( p < 0.05).

Conclusion

This study systematically analyzed the expression characteristics and functional significance of xenobiotic metabolism‐related genes in HCC and LC by integrating multiple high‐throughput sequencing technologies. Experimental validation confirmed the upregulation of these hub genes in clinical tissues and demonstrated that ALDH2 and AKR1C3 promote hepatoma cell migration and invasion, providing experimental evidence for their potential roles in disease progression. Potential drugs targeting these hub genes were preliminarily investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver CirrhosisXenobioticsGene Expression ProfilingHumansGene Expression Regulation, NeoplasticSingle-Cell Gene Expression AnalysisDisease ProgressionCell Line, TumorSingle-Cell AnalysisGene Regulatory NetworksComputational BiologyProtein Interaction MapsTranscriptome

Stichwörter der Autor:innen

hepatocellular carcinomaliver cirrhosismachine leaningsingle-cell RNA-seqxenobiotic metabolism

Substanzen

Xenobiotics

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, zdsfy.net.
  • Zhengzhou Key Laboratory for In Vitro Diagnosis of Hypertensive Disorders of Pregnancy, Zhengzhou, Henan, China.
  • Department of Emergency, Hebei General Hospital, Shijiazhuang, Hebei, China, hebmu.edu.cn.
  • Department of Gastrointestinal Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China, hebmu.edu.cn.
  • Department of Surgical Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China, hebmu.edu.cn.

ORCID-Profile: Shaowei Ma, Ning Hu, Shuo Yu, Xuefeng Lv

Zitieren

APA

Xu, H., Li, Y., Zhao, R., Ma, S., Hu, N., Yu, S., & Lv, X. (2026). Integrated Bulk and Single‐Cell Transcriptomic Analysis Reveals Xenobiotic Metabolism Genes Drive Progression From Liver Cirrhosis to Hepatocellular Carcinoma. Human Mutation, 2026(1). https://doi.org/10.1155/humu/6845605

Vancouver

Xu H, Li Y, Zhao R, Ma S, Hu N, Yu S, et al. Integrated Bulk and Single‐Cell Transcriptomic Analysis Reveals Xenobiotic Metabolism Genes Drive Progression From Liver Cirrhosis to Hepatocellular Carcinoma. Human Mutation. 2026;2026(1). doi:10.1155/humu/6845605

BibTeX
@article{Xu2026,
  author = {Xu, Hao and Li, Yanpeng and Zhao, Rui and Ma, Shaowei and Hu, Ning and Yu, Shuo and Lv, Xuefeng},
  title = {Integrated Bulk and Single‐Cell Transcriptomic Analysis Reveals Xenobiotic Metabolism Genes Drive Progression From Liver Cirrhosis to Hepatocellular Carcinoma},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/6845605}
}
Kostenlos starten →